Sentinel lymph nodes of colorectal carcinoma: Reappraisal of 123 cases;Le ganglion sentinelle dans les cancers colorectaux: Étude de réévaluation sur 123 cas

Gastroenterologie Clinique et Biologique

Volumn 31, Issue 3, 2007, Pages 281-285

  Liberale, Gabriel ^a   Lasser, Philippe ^a   Sabourin, Jean Christophe ^a   Malka, David ^b   Duvillard, Pierre ^a   Elias, Dominique ^a   Boige, Valérie ^b   Goéré, Diane ^a   Ducreux, Michel ^b   Pocard, Marc ^a,c  

^a HÔPITAL CHARLES NICOLLE   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CANCER PATIENT; CLINICAL DECISION MAKING; COLORECTAL CARCINOMA; DIAGNOSTIC ACCURACY; FALSE NEGATIVE RESULT; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; SENTINEL LYMPH NODE; STAINING;

EID: 34147179953     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-8320(07)89374-2     Document Type: Article

References (41)

1. Bouvier AM, Remontet L, Jougla E, Launoy G, Grosclaude P, Buemi A, et al. Incidence of gastrointestinal cancers in France. Gastroenterol Clin Biol 2004;28:877-81.
2. O'Connell MJ, Mailliard JA, Kahn MJ, Macdonald JS, Haller DG, Mayer RJ, et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 1997;15:246-50.
3. Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343-51.
4. Herrera-Ornelas L, Justiniano J, Castillo N, Petrelli NJ, Stulc JP, Mittelman A. Metastases in small lymph nodes from colon cancer. Arch Surg 1987;122:1253-6.
5. Rouffet F, Hay JM, Vacher B, Fingerhut A, Elhadad A, Flamant Y, et al. Curative resection for left colonic carcinoma: hemicolectomy vs. segmental colectomy. A prospective, controlled, multicenter trial. French Association for Surgical Research. Dis Colon Rectum 1994;37:651-9.
6. Hida J, Mori N, Kubo R, Matsuda T, Morikawa E, Kitaoka M, et al. Metastases from carcinoma of the colon and rectum detected in small lymph nodes by the clearing method. J Am Coll Surg 1994;178:223-8.
7. Goldstein NS, Sanford W, Coffey M, Layfield LJ. Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 1996;106:209-16.
8. Hermanek P, Hutter RVP, Sobin LH. TNM atlas. Illustrated guide to the TNM/pTNM classification of malignant tumours. Fourth ed. Berlin : Springer, 1997.
9. Morikawa E, Yasutomi M, Shindou K, Matsuda T, Mori N, Hida J, et al. Distribution of metastatic lymph nodes in colorectal cancer by the modified clearing method. Dis Colon Rectum 1994;37:219-23.
10. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-66.
11. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
12. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-8.
13. Feig BW, Curley S, Lucci A, Hunt KK, Vauthey JN, Mansfield PF, et al. A caution regarding lymphatic mapping in patients with colon cancer. Am J Surg 2001;182:707-12.
14. Read TE, Fleshman JW, Caushaj PF. Sentinel lymph node mapping for adenocarcinoma of the colon does not improve staging accuracy. Dis Colon Rectum 2005;48:80-5.
15. Joosten JJ, Strobbe LJ, Wauters CA, Pruszczynski M, Wobbes T, Ruers TJ. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 1999;86:482-6.
16. Saha S, Wiese D, Badin J, Beutler T, Nora D, Ganatra BK, et al. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol 2000;7:120-4.
17. Tsioulias GJ, Wood TF, Morton DL, Bilchik AJ. Lymphatic mapping and focused analysis of sentinel lymph nodes upstage gastrointestinal neoplasms. Arch Surg 2000;135:926-32.
18. Saha S, Bilchik A, Wiese D, Espinoza M, Badin J, Ganastra BK, et al. Ultrastaging of colorectal cancer by sentinel lymph node mapping technique-a multicenter trial. Ann Surg Oncol 2001;8(9 Suppl):94S-98S.
19. Lasser P, Cote JF, Sabourin JC, Boige V, Elias D, Duvillard P, et al. Is sentinel lymph node mapping relevant for colon cancer?: a feasibility study. Ann Chir 2003;128:433-7.
20. Bell SW, Mourra N, Flejou JF, Parc R, Tiret E. Ex vivo sentinel lymph node mapping in colorectal cancer. Dis Colon Rectum 2005;48:74-9.
21. Bertagnolli M, Miedema B, Redston M, Dowell J, Niedzwiecki D, Fleshman J, et al. Sentinel node staging of resectable colon cancer: results of a multicenter study. Ann Surg 2004;240:624-8.
22. Wood TF, Saha S, Morton DL, Tsioulias GJ, Rangel D, Hutchinson W Jr, et al. Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol 2001;8:150-7.
23. Bilchik AJ, Saha S, Wiese D, Stonecypher JA, Wood TF, Sostrin S, et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol 2001;19:1128-36.
24. Saha S, Monson KM, Bilchik A, Beutler T, Dan AG, Schochet E, et al. Comparative analysis of nodal upstaging between colon and rectal cancers by sentinel lymph node mapping: a prospective trial. Dis Colon Rectum 2004;47:1767-72.
25. Baton O, Lasser P, Sabourin JC, Boige V, Duvillard P, Elias D, et al. Ex vivo sentinel lymph node study for rectal adenocarcinoma: preliminary study. World J Surg 2005;29:1166-70, discussion.
26. Bembenek A, Schneider U, Gretschel S, Fischer J, Schlag PM. Detection of lymph node micrometastases and isolated tumor cells in sentinel and nonsentinel lymph nodes of colon cancer patients. World J Surg 2005;29:1172-5.
27. Wood TF, Saha S, Morton DL, Tsioulias GJ, Rangel D, Hutchinson W, Jr., et al. Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol 2001;8:150-7.
28. Fisher ER, Colangelo L, Wieand S, Fisher B, Wolmark N. Lack of influence of cytokeratin-positive mini micrometastases in "Negative Node" patients with colorectal cancer: findings from the national surgical adjuvant breast and bowel projects protocols R-01 and C-01. Dis Colon Rectum 2003;46:1021-5.
29. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JH, Cornelisse CJ, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998;339:223-8.
30. Kronberg U, Lopez-Kostner F, Soto G, Zuniga A, Wistuba I, Miranda V, et al. Detection of lymphatic micrometastases in patients with stages I and II colorectal cancer: impact on five-year survival. Dis Colon Rectum 2004;47:1151-7.
31. Doekhie FS, Kuppen PJ, Peeters KC, Mesker WE, van Soest RA, Morreau H, et al. Prognostic relevance of occult tumour cells in lymph nodes in colorectal cancer. Eur J Surg Oncol 2006;32:253-8.
32. Compton CC, Greene FL. The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin 2004;54:295-308.
33. Doekhie FS, Peeters KC, Kuppen PJ, Mesker WE, Tanke HJ, Morreau H, et al. The feasibility and reliability of sentinel node mapping in colorectal cancer. Eur J Surg Oncol 2005;31:854-62.
34. Gandy CP, Biddlestone LR, Roe AM, O'Leary DP. Intra-operative injection of Patent Blue V dye to facilitate nodal staging in colorectal cancer. Colorectal Dis 2002;4:447-9.
35. Paramo JC, Summerall J, Wilson C, Cabral A, Willis I, Wodnicki H, et al. Intraoperative sentinel lymph node mapping in patients with colon cancer. Am J Surg 2001;182:40-3.
36. Viehl CT, Hamel CT, Marti WR, Guller U, Eisner L, Stammberger U, et al. Identification of sentinel lymph nodes in colon cancer depends on the amount of dye injected relative to tumor size. World J Surg 2003;27:1285-90.
37. Braat AE, Oosterhuis JW, Moll FC, de Vries JE, Wiggers T. Sentinel node detection after preoperative short-course radiotherapy in rectal carcinoma is not reliable. Br J Surg 2005;92:1533-8.
38. Leong SP, Donegan E, Heffernon W, Dean S, Katz JA. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol 2000;7:361-6.
39. Seto Y, Yamaguchi H, Shimoyama S, Shimizu N, Aoki F, Kaminishi M. Results of local resection with regional lymphadenectomy for early gastric cancer. Am J Surg 2001;182:498-501.
40. Ishizaki M, Kurita A, Kubo Y, Takashima S, Nishina T, Nishimura E. Evaluation of sentinel node identification with isosulfan blue in gastric cancer. Eur J Surg Oncol 2006;32:191-6.
41. Pocard M, Van den EM, Goere D, Boige V, Malka D. Sentinel lymph node sampling and analysis in colon cancer: what is the question? J Clin Oncol 2006;24:3712-3.